Health Care Equipment & Supplies · Nasdaq

IDXXIdexx Laboratories Inc

Last close
$704.23 +0.9%
52-week range
$500.61 to $769.98
Market cap
$55.5B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$4.30B
+10% vs FY24
Net income
$1.06B
+19% vs FY24
Free cash flow
$1.06B
+31% vs FY24
Net cash
-$270M
Cash $180M, debt $450M

Stock price

+496% since Dec 2016

Valuation vs its own 10 years

Below its 10-year median on 3 of 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
47.5x
35.2x76.5x
25th percentile, below its median of 52.7x
Price / sales
11.9x
6.0x18.0x
68th percentile, above its median of 10.2x
EV / EBITDA
33.4x
24.9x57.5x
45th percentile, below its median of 34.3x
Price / free cash flow
42.6x
31.7x92.1x
15th percentile, below its median of 60.7x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
47.5x
Earnings yield
2.1%
Price / sales
11.9x
Price / book
29.7x
Price / operating cash flow
39.1x
EV / EBITDA
33.4x
EV / sales
11.9x
Free cash flow yield
2.4%

Profitability

Gross margin
62.7%
Operating margin
32.3%
Net margin
25.4%
Return on equity
63.2%
Return on capital
53.6%

Growth per year

Revenue, 3 years
+8.5%
Revenue, 5 years
+9.7%
Revenue, 9 years
+10.3%
EPS, 3 years
+17.7%

Balance sheet

Cash and investments
$198M
Total debt
$375M
Net cash
-$177M
Debt / equity
0.20x
Current ratio
1.19x

Shares and dividend

Shares outstanding
78.8M
Share count, 5 years
-6.6%
Beta, 1 year
0.82
Dividend yield
n/a
Dividend per share, TTM
n/a
Payout ratio
n/a

n/a: No dividend

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $1.21B
RevenueNet income
Gross profitLatest quarter $764M
EBITDALatest quarter $443M
Margins63 / 33 / 26%
GrossOperatingNet
Earnings per shareLatest quarter $4.01
Cash flowLatest quarter $450M
OperatingCapexFree
Cash vs debtLatest quarter $198M
Cash and investmentsTotal debt
P/E historyNow 47.5x
P/E, median 52.7x dashed
P/S historyNow 11.9x
P/S, median 10.2x dashed

Where the revenue comes from

Product went from 57% to 59% of revenue in 3 years

Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.

ProductServices
FY22
57%43%
$3.37B
FY23
57%43%
$3.66B
FY24
58%42%
$3.90B
FY25
59%41%
$4.30B
Fiscal 2025 by product line
Product lineRevenueSharevs FY24
Product$2.54B59.0%+13%
Services$1.76B41.0%+7%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
IDXX Idexx Laboratories Inc $55.5B +12% 32.3%47.5x11.9x 25th percentile

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
Founded
1983
Headquarters
Westbrook, ME
Fiscal year ends
December
Website
idexx.com

What it does

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about IDXX.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 994 active funds. Crowd level: quiet.

Open the Smart money tab